PFCS
EWTX icon

Pale Fire Capital SE’s Edgewise Therapeutics EWTX Stock Holding History

Pale Fire Capital SE’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,686
Closed -$205K – 58
2024
Q3 		$205K Buy
+7,686
New +$153K 0.03% 42
2024
Q1 		– Sell
-98,449
Closed -$1.08M – 62
2023
Q4 		$1.08M Buy
98,449
+82,804
+529% +$581K 0.17% 30
2023
Q3 		$89.6K Buy
+15,645
New +$106K 0.01% 55

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Pale Fire Capital SE's EWTX Position: Q4 2024 in Review

Pale Fire Capital SE sold out of Edgewise Therapeutics (EWTX) in Q4 2024, closing a stake of 7,686 shares — an estimated $205K sold.

Pale Fire Capital SE first reported a position in EWTX in Q3 2023 and held it in 3 quarters. The position peaked at $1.08M in Q4 2023. 200 funds tracked by Wall St. Rank hold EWTX as of Q4 2024.

  • Pale Fire Capital SE reported no remaining Edgewise Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Pale Fire Capital SE sold 7,686 Edgewise Therapeutics shares in Q4 2024, an estimated $205K.
  • Pale Fire Capital SE first reported a position in Edgewise Therapeutics in Q3 2023 and held it in 3 quarters.
  • Pale Fire Capital SE's Edgewise Therapeutics position peaked at $1.08M in Q4 2023.
  • 200 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q4 2024.

Based on Pale Fire Capital SE's 13F filing for Q4 2024, filed 13 Feb 2025.